推进2025年循证学术研究

Bibliography of Published Papers and PresentationsUsing IQVIA Information Introduction Evidence-based research is vitally important in the rapidly evolving, complex,and unpredictable healthcare landscape. Therefore, researchers worldwide relyheavily on IQVIA’s data and insights to deepen understanding of disease trends,healthcare expenditures, policy dynamics, and real-world clinical outcomes.These research activities highlight the growing importance of Human DataScience — a multidisciplinary field that merges human science, data analytics,and health expertise. Collaborative research efforts with academic institutions andother partners are central to IQVIA’s mission as a global leaderin information and technology services. These partnershipshelp expand knowledge in areas such as health systems,patient care patterns, and policy development, resulting in asubstantial volume of peer-reviewed articles and conferencecontributions across diverse healthcare topics. • Providing context for healthcare costs• Assessing policy levers for health interventions• Advancing real-world patient-level clinical evidence Together, these studies reflect a significant advancementin understanding how our healthcare system functionsin real-world settings, and how the healthcare system issubject to continued changes that impact patients, clinicians,providers, payers, policymakers, and other stakeholders.Overall, research focused on understanding disease andtreatment patterns represents the most prominent categoryamong published studies. The scope of data used in these studies is broad, andthe number of publications leveraging IQVIA’s resourcescontinues to grow. This bibliography captures 80publications from the second half of 2024 and 133 fromthe first half of 2025, reflecting the increasing use ofIQVIA data in scholarly research. This bibliography has been produced as a public servicewithout industry or government funding. The studies draw from a wide array of sources,including aggregated global and national prescriptiondata, provider-level prescribing patterns, anonymizedlongitudinal patient records, healthcare provider profilesand affiliations, and commercial insurance claims formedical and pharmacy services. Find Out More If you wish to receive future reports from the IQVIAInstitute for Human Data Science and hear about eventsand other activities, join our mailing list via the subscribebutton at www.iqviainstitute.org. If you have questions,contact us at info@iqviainstitute.org IQVIA values, protects, and defends privacy and theresponsible use of information. The company champions thelaws, practices and principles that help our industry handleinformation about people responsibly with trust and integrity. MURRAY AITKEN Executive DirectorIQVIA Institute for Human Data Science The content of this bibliography is organized in reversechronological order by publication date and segmentedinto five themes: • Examining current trends in healthcare research• Understanding disease and treatment patterns REFERENCING THIS REPORTPlease use this format when referencing content from this report: Source: IQVIA Institute for Human Data Science. Advancing Evidence-Based Academic Research 2025: Bibliography of Published Papersand Presentations, September 2025. ©2025 IQVIA and its affiliates. All reproduction rights, quotations, broadcasting, publications reserved. No part of this publication may be reproduced ortransmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, withoutexpress written consent of IQVIA and the IQVIA Institute. Table of Contents Examining current trends in healthcare research2Understanding disease and treatment patterns4Providing context for healthcare costs12Assessing policy levers for health interventions14Advancing real-world patient-level clinical evidence15About the Institute18 Examining current trends in healthcare research A rising trend in health research is the growing reliance on real-world evidence to uncover how diseases aretreated and managed across varied clinical environments. This approach is gaining momentum, especially instudies involving biologics and biosimilars, the expanding use of GLP-1 therapies for metabolic conditions,and large-scale data initiatives like OHDSI that enable large-scale, standardized data analysis. By tappinginto real-world data, researchers are better equipped to analyze treatment variability, identify emerging carepatterns, and generate insights that are increasingly shaping the future of healthcare. This diverse set of researchunderscores the growing relevance and utility of real-world evidence in shaping the future of healthcare. Real-world Outcomes Following Biologic Initiationin US Patients with Chronic Rhinosinusitis withNasal PolypsAdvances in Therapy. 2025 Feb BIOLOGICS AND BIOSIMILARS Demand-Versus Supply-Side Policies in MarketPenetration of Biosimilars: Which is